Cargando…

Examining the Clinical Effectiveness of Non-Carbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae

Treatment options for extended-spectrum β-lactamase-producing Enterobacteriaceae are limited. Piperacillin-tazobactam and cefepime represent potential alternative treatment options; however, large prospective studies are lacking. This review evaluates the current literature regarding use of piperaci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gibble, Allison M., Gross, Alan E., Huang, Angela M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790318/ https://www.ncbi.nlm.nih.gov/pubmed/27025645 http://dx.doi.org/10.3390/antibiotics4040653

Ejemplares similares

Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae
por: Wilson, Hayley, et al.
Publicado: (2018)

Comparison Between Carbapenems and β-Lactam/β-Lactamase Inhibitors in the Treatment for Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis
por: Muhammed, Maged, et al.
Publicado: (2017)

1452. Is Carbapenem-Sparing Therapy as Effective as Carbapenems Against Extended-Spectrum β-Lactamase Producing Enterobacteriaceae in UTI?
por: Hyun, Jonghoon, et al.
Publicado: (2019)

Corrigendum: Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae
por: Wilson, Hayley, et al.
Publicado: (2018)

Efficacy of Noncarbapenem β-Lactams Compared to Carbapenems for Extended-Spectrum β-Lactamase–Producing Enterobacterales Urinary Tract Infections
por: Anderson, Daniel T, et al.
Publicado: (2022)

1055. Epidemiology and Mechanisms of Carbapenem Resistance in Recurrent Extended-Spectrum β-Lactamase- Producing Enterobacteriaceae Bacteremia
por: Aitken, Samuel L, et al.
Publicado: (2018)

Extended spectrum β-lactamase producing Enterobacteriaceae & antibiotic co-resistance
por: Rudresh, S.M., et al.
Publicado: (2011)

1483. Comparison of Outcomes in Urinary Tract Infections Caused by SPICE Organisms Treated with Non-Carbapenem-β-lactams vs. Non-β-lactams Agents
por: Sapozhnikov, Julia, et al.
Publicado: (2019)

Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae
por: Viale, Pierluigi, et al.
Publicado: (2015)

Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae in a Malian Orphanage
por: Tandé, Didier, et al.
Publicado: (2009)

Extended-spectrum β-Lactamase–producing Enterobacteriaceae, Central African Republic
por: Frank, Thierry, et al.
Publicado: (2006)

Mother to Child Transmission of Extended Spectrum β-Lactamase Producing Enterobacteriaceae
por: Danino, Dana, et al.
Publicado: (2017)

In vitro potency of xeruborbactam in combination with multiple β-lactam antibiotics in comparison with other β-lactam/β-lactamase inhibitor (BLI) combinations against carbapenem-resistant and extended-spectrum β-lactamase-producing Enterobacterales
por: Lomovskaya, Olga, et al.
Publicado: (2023)

Extended-Spectrum β-Lactamase–producing Enterobacteriaceae among Travelers from the Netherlands
por: Paltansing, Sunita, et al.
Publicado: (2013)

Horizontal Transfer of Antimicrobial Resistance by Extended-Spectrum β Lactamase-Producing Enterobacteriaceae
por: Vaidya, Varsha K
Publicado: (2011)

Recent changes in the epidemiology and management of extended-spectrum β-lactamase-producing Enterobacteriaceae
por: Pitout, Johann DD
Publicado: (2009)

Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America
por: Guzmán-Blanco, Manuel, et al.
Publicado: (2014)

1472. Non-Carbapenems for Treating Community-Associated Urinary Tract Infection Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Children
por: Joo Jung, Hyun, et al.
Publicado: (2019)

In Vitro and In Vivo Evaluations of β-Lactam/β-Lactamase Mono- and Combined Therapies against Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan
por: Yang, Tsung-Ying, et al.
Publicado: (2020)

Characterization of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae From Retail Food in China
por: Ye, Qinghua, et al.
Publicado: (2018)

Psychoactive drug prescription and urine colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae
por: Bachtarzi, Raphaële, et al.
Publicado: (2019)

Cefepime Therapy for Cefepime-Susceptible Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bacteremia
por: Wang, Ruibin, et al.
Publicado: (2016)

Extended spectrum β lactamase-producing Enterobacteriaceae shedding by race horses in Ontario, Canada
por: Shnaiderman-Torban, Anat, et al.
Publicado: (2020)

1053. The β-Lactamase Inhibitor QPX7728 Restores the Activity of β-Lactam Agents against Contemporary Extended-Spectrum β-lactamase (ESBL)-Producing and Carbapenem-Resistant Enterobacterales (CRE) Isolates, Including Isolates Producing Metallo-β-lactamases
por: Lindley, Jill, et al.
Publicado: (2021)

Analyses of Extended-Spectrum-β-Lactamase, Metallo-β-Lactamase, and AmpC-β-Lactamase Producing Enterobacteriaceae from the Dairy Value Chain in India
por: Dey, Tushar Kumar, et al.
Publicado: (2023)

Rates of Fecal Transmission of Extended-Spectrum β-Lactamase-Producing and Carbapenem-Resistant Enterobacteriaceae Among Patients in Intensive Care Units in Korea
por: Kim, Jayoung, et al.
Publicado: (2014)

Drug resistance, AmpC-β-lactamase and extended-spectrum β-lactamase-producing Enterobacteriaceae isolated from fish and shrimp
por: de Almeida, Marília Viana Albuquerque, et al.
Publicado: (2017)

Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae in Fresh Produce
por: Pintor-Cora, Alberto, et al.
Publicado: (2021)

Prevalence and Molecular Characterization of Extended-Spectrum β-Lactamases and AmpC β-lactamase-Producing Enterobacteriaceae among Human, Cattle, and Poultry
por: Nossair, Mohamed A., et al.
Publicado: (2022)

Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae
por: Ng, Tat Ming, et al.
Publicado: (2016)

Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in hospital and community settings in Chad
por: Ouchar Mahamat, Oumar, et al.
Publicado: (2019)

Prevalence of Carbapenemase and Extended-Spectrum β-Lactamase Producing Enterobacteriaceae: A Cross-Sectional Study
por: Mustafai, Muhammad Muqaddas, et al.
Publicado: (2023)

Efficacy of loading dose colistin versus carbapenems for treatment of extended spectrum beta lactamase producing Enterobacteriaceae
por: Katip, Wasan, et al.
Publicado: (2021)

Prevalence of carbapenem-resistant and extended-spectrum beta-lactamase-producing Enterobacteriaceae in a teaching hospital in Ghana
por: Sampah, James, et al.
Publicado: (2023)

211. Disease burden of bacteremia with extended-spectrum beta-lactamase-producing or carbapenem-resistant Enterobacteriaceae in Korea
por: Mi Lee, Chan, et al.
Publicado: (2023)

Epidemiology of and risk factors for infection with extended-spectrum β-lactamase-producing carbapenem-resistant Enterobacteriaceae: results of a double case–control study
por: Tian, Xiaolang, et al.
Publicado: (2018)

Multimodal Interventions to Prevent and Control Carbapenem-Resistant Enterobacteriaceae and Extended-Spectrum β-Lactamase Producer-Associated Infections at a Tertiary Care Hospital in Egypt
por: Kamel, Noha A., et al.
Publicado: (2021)

Efficacy of Admission Screening for Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae
por: Lowe, Christopher F., et al.
Publicado: (2013)

2261. Oral Fosfomycin for Treatment of Urinary Tract Infections Due to Extended-Spectrum β-Lactamase and Carbapenem-Resistant Enterobacteriaceae
por: Hefler, Jade L, et al.
Publicado: (2019)

2479. Trends and Regional Differences in Extended Spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, 2012–2017
por: Wolford, Hannah, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9sjbnd4lk1crns2katatf9leap